Skip to main content
Jasmine Zain, MD, Oncology, Duarte, CA

Jasmine Zain MD

Cutaneous Lymphoma, Hematologic Oncology


Professor Department of Hematology and Hemoatopoeitic stem cell transplantation Director T cell Lymphoma program

Request Appointment
  • 1500 Duarte RdDuarte, CA 91010

  • Book by Phone+1(309) 237-5195

Overview of  Dr. Zain

Dr. Jasmine Zain is an oncologist in Duarte, CA and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from Fatima Jinnah Medical College and has been in practice 30 years. Dr. Zain accepts several types of health insurance, listed below. She is one of 504 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. She has more than 100 publications and over 500 citings.

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1996 - 1999
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1995 - 1997
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1994 - 1995
  • Zucker School of Medicine at Hofstra/Northwell at Forest Hills Hospital
    Zucker School of Medicine at Hofstra/Northwell at Forest Hills HospitalResidency, Internal Medicine, 1989 - 1992
  • Fatima Jinnah Medical College
    Fatima Jinnah Medical CollegeClass of 1987

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2025 - Present
  • NJ State Medical License
    NJ State Medical License 2024 - 2027
  • CA State Medical License
    CA State Medical License 2002 - 2025
  • NY State Medical License
    NY State Medical License 1994 - 2025
  • CT State Medical License
    CT State Medical License 2001 - 2003
  • NC State Medical License
    NC State Medical License 1992 - 2001
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Long Term Outcomes of Patients with Aggressive T-Cell Non-Hodgkin Lymphoma Undergoing Allogeneic Stem Cell Transplantation: Retrospective Results from a Single Center
    Jasmine M. Zain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Blinatumomab/Lenalidomide in Relapsed/Refractory Non-HodgkinÍs Lymphoma: A Phase I California Cancer Consortium Study of Safety, Efficacy and Immune Correlative Analysis
    Jasmine Zain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Phase 1 Results of Anti-PD-Ligand 1 (Durvalumab) & Lenalidomide in Patients with Cutaneous T Cell Lymphoma and Correlation with Programmed Death Ligand 1 Expression an...
    Jasmine Zain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Preliminary Results of the Stapled Peptide ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Two Phase IIa Dose Expansion Cohorts in Relapsed/Refractory TP53 Wild-Type ... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Pembrolizumab in Patients with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): Data from the Keynote-013 and Keynote-170 StudiesClinically Re... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • 6th Annual Conference On How The Experts Treat Hematologic Malignancies 
    City of Hope, Santa Monica, California - 9/18/2013

Press Mentions

  • City of Hope Doctors and Scientists Present Research on Novel Cancer Therapies at American Society of Hematology (ASH) Annual Conference
    City of Hope Doctors and Scientists Present Research on Novel Cancer Therapies at American Society of Hematology (ASH) Annual ConferenceDecember 10th, 2024
  • City of Hope Doctors Present Research on First KRAS Inhibitor and CAR T Cell Therapy at ASCO
    City of Hope Doctors Present Research on First KRAS Inhibitor and CAR T Cell Therapy at ASCOMay 29th, 2019
  • City of Hope Clinical and Laboratory Investigators Present New Research at the 60
    City of Hope Clinical and Laboratory Investigators Present New Research at the 60December 4th, 2018

Committees

  • Co-Chair, CPRMC (Cancer Protocol Regulatory and Monitoring Committee), City of Hope National Medical Center 2017 - Present
  • Member, CPRMC (Cancer Protocol Regulatory and Monitoring Committee), City of Hope National Medical Center 2016 - 2017

Professional Memberships

  • American Society of Hematology
    Member
  • American Society of Oncology
    Member
  • Member
  • American Society for Blood and Marrow Transplantation
    Member
  • International Society of Cutaneous Lymphoma
    Member
  • Southwest Oncology Group
    Member

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    GHI PPO
    Great West PPO
    Health Net Oregon PPO
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    MagnaCare PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: